Early Trial Offers Hope Treating Rare 'Brittle Bone' Disease

MONDAY, Feb. 21, 2022 (HealthDay News) -- An experimental drug may help build bone mass in some adults with a rare brittle-bone disease, a small preliminary study suggests.

Related Keywords

New York , United States , Houston , Texas , Hospital For Special Surgery , Baylor College Of Medicine , Brendan Lee , Cathleen Raggio , Sanofi Genzyme , Brittle Bone Disorders Consortium , Us National Institutes Of Health , Drug Administration , Healthday News , Baylor College , Special Surgery , Clinical Investigation , Consumer News ,